Free Trial

Cutera Q3 2023 Earnings Report

Cutera logo
$0.04 -0.07 (-63.86%)
As of 03/12/2025
This is a fair market value price provided by Polygon.io. Learn more.

Cutera EPS Results

Actual EPS
-$2.22
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cutera Revenue Results

Actual Revenue
$46.48 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cutera Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Remove Ads

Cutera Earnings Headlines

StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)
Two new option listings and two option delistings on March 13th
Game Over for Tesla?
Tesla is down 50% from its high... Our research indicates investors are waking up to the fact that Tesla is no longer Musk's #1 priority. His real goal is political power - and his private AI firm xAI. He recently bought over $1 billion worth of AI chips from NVIDIA... And is about to spend $5 billion on yet another data center for xAI.
Cutera Inc to delist from NASDAQ amid bankruptcy
Cutera plans Nasdaq delisting and SEC reporting halt
Cutera intends to delist shares from Nasdaq
See More Cutera Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cutera? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cutera and other key companies, straight to your email.

About Cutera

Cutera (NASDAQ:CUTR) provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

View Cutera Profile

More Earnings Resources from MarketBeat